Survival rate of gastric cancer in Iran; a systematic review and meta-analysis
- PMID: 27099666
- PMCID: PMC4833845
Survival rate of gastric cancer in Iran; a systematic review and meta-analysis
Abstract
Aim: In this study, we aimed to estimate one- to five-year survival rates in Iranian patients with gastric cancer (GC). In addition, we preformed subgroup analyses and meta-regression to explore possible sources of heterogeneity between studies.
Background: According to literatures, there has been increasing attention to the long-term survival rate in patients with GC in Iran. However, results have been inconsistent and remain controversial in overall survival rates.
Patients and methods: Literature searches were conducted using PubMed, Scopus, and ISI, as well as Magiran, Medlib, SID, and Iran Medex databases. Studies were pooled and summary one to five survival rates were calculated. Univariate and multivariate regression analyses were used to explore possible sources of heterogeneity among studies. Subgroup analyses were also conducted. Analyses were conducted using the STATA statistical software package.
Results: Final analysis of 29361 patients from 26 eligible studies was performed. The overall survival rate (one to five years) in all studies, by meta-analysis of 24, 14, 23, 12 and 22 studies were 52%, 31%, 24%, 22%, and 15%, respectively. Meta-regression analysis showed an increase in one- and five-year survival rate over the time (Reg Coef = 0.016, p= 0.04) and (Reg Coef= 0.021, p= 0.049), respectively. Positive heterogeneity was observed between quality of papers and data sources (P<0.001).
Conclusion: More than half of GC deaths happened in the first year at diagnosis, and another 30% plus they occurred during the second year after confirmed diagnosis. Our results admit lower survival rates in Iran, similar to other developing countries.
Keywords: Gastric cancer; Heterogeneityndrial; Meta-analysis; Survival rate; Systematic review.
Figures



Similar articles
-
Survival of gastric cancer patients in Iran: a systematic review and meta-analysis.Gastroenterol Hepatol Bed Bench. 2023;16(3):245-258. doi: 10.22037/ghfbb.v16i2.2674. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37767325 Free PMC article. Review.
-
5-year survival rates based on the type of leukemia in Iran, a Meta-analysis.Caspian J Intern Med. 2018 Fall;9(4):316-324. doi: 10.22088/cjim.9.4.316. Caspian J Intern Med. 2018. PMID: 30510644 Free PMC article. Review.
-
Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2019 Jan 25;20(1):13-21. doi: 10.31557/APJCP.2019.20.1.13. Asian Pac J Cancer Prev. 2019. PMID: 30677864 Free PMC article.
-
Survival Rate of Esophageal Carcinoma in Iran - A Systematic Review and Meta-analysis.Iran J Cancer Prev. 2014 Spring;7(2):61-5. Iran J Cancer Prev. 2014. PMID: 25250151 Free PMC article. Review.
-
Survival Rate of Breast Cancer in Iran: A Meta-Analysis.Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4615-4621. doi: 10.22034/apjcp.2016.17.10.4615. Asian Pac J Cancer Prev. 2016. PMID: 27892673 Free PMC article.
Cited by
-
Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial.Caspian J Intern Med. 2021 Apr;12(3):256-262. doi: 10.22088/cjim.12.3.256. Caspian J Intern Med. 2021. PMID: 34221274 Free PMC article.
-
Trend in Gastric Cancer Mortality in Kazakhstan.Asian Pac J Cancer Prev. 2022 Nov 1;23(11):3779-3789. doi: 10.31557/APJCP.2022.23.11.3779. Asian Pac J Cancer Prev. 2022. PMID: 36444591 Free PMC article.
-
Survival rate of patients with gastric cancer in Hormozgan Province, Iran.Med J Islam Repub Iran. 2019 Jul 24;33:74. doi: 10.34171/mjiri.33.74. eCollection 2019. Med J Islam Repub Iran. 2019. PMID: 31696068 Free PMC article.
-
Estimating the Net Survival of Patients with Gastric Cancer in Iran in a Relative Survival Framework.Iran J Med Sci. 2018 Nov;43(6):605-611. Iran J Med Sci. 2018. PMID: 30510337 Free PMC article.
-
Survival of gastric cancer patients in Iran: a systematic review and meta-analysis.Gastroenterol Hepatol Bed Bench. 2023;16(3):245-258. doi: 10.22037/ghfbb.v16i2.2674. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37767325 Free PMC article. Review.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917. - PubMed
-
- Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran—A population based study. Int J Cancer. 2009;125:1953–60. - PubMed
-
- Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–92. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous